These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 21811460)

  • 1. Risk of Upper Gastrointestinal Bleeding in a Cohort of New Users of Low-Dose ASA for Secondary Prevention of Cardiovascular Outcomes.
    Cea Soriano L; Rodríguez LA
    Front Pharmacol; 2010; 1():126. PubMed ID: 21811460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of upper gastrointestinal bleeding with low-dose acetylsalicylic acid alone and in combination with clopidogrel and other medications.
    García Rodríguez LA; Lin KJ; Hernández-Díaz S; Johansson S
    Circulation; 2011 Mar; 123(10):1108-15. PubMed ID: 21357821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mortality in patients who discontinue low-dose acetylsalicylic acid therapy after upper gastrointestinal bleeding.
    González-Pérez A; Sáez ME; Johansson S; Nagy P; García Rodríguez LA
    Pharmacoepidemiol Drug Saf; 2017 Feb; 26(2):215-222. PubMed ID: 27921360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of upper gastrointestinal ulcer bleeding associated with selective cyclo-oxygenase-2 inhibitors, traditional non-aspirin non-steroidal anti-inflammatory drugs, aspirin and combinations.
    Lanas A; García-Rodríguez LA; Arroyo MT; Gomollón F; Feu F; González-Pérez A; Zapata E; Bástida G; Rodrigo L; Santolaria S; Güell M; de Argila CM; Quintero E; Borda F; Piqué JM;
    Gut; 2006 Dec; 55(12):1731-8. PubMed ID: 16687434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular and upper gastrointestinal bleeding consequences of low-dose acetylsalicylic acid discontinuation.
    Cea Soriano L; Bueno H; Lanas A; García Rodríguez LA
    Thromb Haemost; 2013 Dec; 110(6):1298-304. PubMed ID: 24008261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of bleeding after hospitalization for a serious coronary event: a retrospective cohort study with nested case-control analyses.
    González-Pérez A; Sáez ME; Johansson S; Himmelmann A; García Rodríguez LA
    BMC Cardiovasc Disord; 2016 Aug; 16(1):164. PubMed ID: 27577589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of Upper and Lower Gastrointestinal Bleeding in New Users of Low-Dose Aspirin.
    Cea Soriano L; Lanas A; Soriano-Gabarró M; García Rodríguez LA
    Clin Gastroenterol Hepatol; 2019 Apr; 17(5):887-895.e6. PubMed ID: 29908361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns in the use of low-dose acetylsalicylic acid and other therapies following upper gastrointestinal bleeding.
    Sáez ME; González-Pérez A; Johansson S; Nagy P; García Rodríguez LA
    Am J Cardiovasc Drugs; 2014 Dec; 14(6):443-50. PubMed ID: 25119521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acid suppressants reduce risk of gastrointestinal bleeding in patients on antithrombotic or anti-inflammatory therapy.
    Lin KJ; Hernández-Díaz S; García Rodríguez LA
    Gastroenterology; 2011 Jul; 141(1):71-9. PubMed ID: 21458456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of antisecretory drugs and nitrates on the risk of ulcer bleeding associated with nonsteroidal anti-inflammatory drugs, antiplatelet agents, and anticoagulants.
    Lanas A; García-Rodríguez LA; Arroyo MT; Bujanda L; Gomollón F; Forné M; Aleman S; Nicolas D; Feu F; González-Pérez A; Borda A; Castro M; Poveda MJ; Arenas J;
    Am J Gastroenterol; 2007 Mar; 102(3):507-15. PubMed ID: 17338735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased risk of stroke after discontinuation of acetylsalicylic acid: a UK primary care study.
    García Rodríguez LA; Cea Soriano L; Hill C; Johansson S
    Neurology; 2011 Feb; 76(8):740-6. PubMed ID: 21270415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors associated with NSAID-induced upper gastrointestinal bleeding resulting in hospital admissions: A cross-sectional, retrospective, case series analysis in valencia, spain.
    Marco JL; Amariles P; Boscá B; Castelló A
    Curr Ther Res Clin Exp; 2007 Mar; 68(2):107-19. PubMed ID: 24678124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of uncomplicated peptic ulcer disease in a cohort of new users of low-dose acetylsalicylic acid for secondary prevention of cardiovascular events.
    Ruigómez A; Johansson S; Nagy P; Martín-Pérez M; Rodríguez LA
    BMC Gastroenterol; 2014 Dec; 14():205. PubMed ID: 25492031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The incidence, clinical characteristics and risk factors of upper gastrointestinal bleeding in patients taking dual antiplatelet therapy after percutaneous coronary intervention in south China].
    Zhang ZF; Sha WH; Tan GY; Wang QY
    Zhonghua Nei Ke Za Zhi; 2016 Jun; 55(6):445-50. PubMed ID: 27256606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-dose aspirin and risk of upper/lower gastrointestinal bleeding by bleed severity: a cohort study with nested case-control analysis using primary care electronic health records from the United Kingdom.
    García Rodríguez LA; Lanas A; Soriano-Gabarró M; Cea Soriano L
    Ann Med; 2019 Mar; 51(2):182-192. PubMed ID: 31025592
    [No Abstract]   [Full Text] [Related]  

  • 16. Predictors and time trends in clopidogrel and proton pump inhibitor coprescription with low-dose acetylsalicylic acid.
    Cea Soriano L; Bueno H; Johansson S; García Rodríguez LA
    Pharmacoepidemiol Drug Saf; 2012 May; 21(5):463-9. PubMed ID: 22298501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence and predictors of upper gastrointestinal bleeding in patients receiving low-dose aspirin for secondary prevention of cardiovascular events in patients with coronary artery disease.
    Ng W; Wong WM; Chen WH; Tse HF; Lee PY; Lai KC; Li SW; Ng M; Lam KF; Cheng X; Lau CP
    World J Gastroenterol; 2006 May; 12(18):2923-7. PubMed ID: 16718820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-dose aspirin and upper gastrointestinal bleeding in primary versus secondary cardiovascular prevention: a population-based, nested case-control study.
    Lin KJ; De Caterina R; García Rodríguez LA
    Circ Cardiovasc Qual Outcomes; 2014 Jan; 7(1):70-7. PubMed ID: 24254886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk Factors for Upper Gastrointestinal Bleeding in Patients Taking Selective COX-2 Inhibitors: A Nationwide Population-Based Cohort Study.
    Lin XH; Young SH; Luo JC; Peng YL; Chen PH; Lin CC; Chen WM; Hou MC; Lee FY
    Pain Med; 2018 Feb; 19(2):225-231. PubMed ID: 28460044
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.